Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
-To assess the safety and tolerability of single doses of odanacatib in mature adolescents. -To compare plasma pharmacokinetic parameters [AUC0-∞, AUC0-168hr, Cmax, C168hr, Tmax, apparent terminal t½] following a single oral dose of odanacatib 10 mg (Panel A) between mature adolescents and adult historical controls and 50 mg (Panel B) between mature adolescents and young adults (Panel C).
Critère d'inclusion
- Osteoporosis